Abbott Laboratories announces $5 billion buyback plan
Health care products company Abbott Laboratories will buy up to $5 billion in stock under a newly announced share buyback program.
According to a Securities and Exchange commission filing, North Chicago-based Abbott had just over 1.54 billion shares of common stock outstanding as of June 30. The buyback program has no time limit.
Shares of Abbott closed at $49.45 Friday.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.